Skip to content

The Importance of USP <800> and its Application in the Compounding Setting

This activity is designed to meet the educational needs of compounding pharmacists.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Identify who is affected by the provisions of USP <800> and why these regulations are important.
  • Define USP <800> and hazardous drug as classified by NIOSH.
  • Formulate a plan for implementing USP <800> regulations to both a sterile and non-sterile compounding pharmacy setting.


Paige Choi
Paige Choi (formerly Richardson) works as a Compounding Pharmacist for PerforMIX Specialty Pharmacy overseeing non-sterile compounding of both hazardous and non-hazardous drugs. She is a 2015 graduate of MCPHS University, beginning her career working as a clinical pharmacist at Holy Family Hospital in Methuen, MA, and as an adjunct faculty member in the Institutional Practice Compounding Lab at MCPHS University. She has previously held positions at Tufts Medical Center as a sterile compounding Clinical Pharmacist and at Atrius Health as an Oncology/ Hematology Clinical Pharmacist, assisting in overseeing the sterile-compounding of hazardous drugs. Paige enjoys being able to combine her interest in compounding with her desire to teach others and has previously presented continuing education focused on USP <795> and <797>, including presenting at the 2017 at the New England Pharmacists’ Convention in CT.

Registration Fee: Free to MCPHS Alumni and full-time employees; $12.00 for all other professionals.


ACPE logo

Release Date: November 11, 2020
Expiration Date: November 11, 2021
Contact Hours: 1.00
Universal Activity Number: 0026-0000-20-220-H03-P


MCPHS University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1 contact hours (0.1 CEUs).

Requirements for Credit

In order to receive credit, the participant must review the entire presentation and complete the post-test and evaluation form. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

MCPHS University adheres to the ACPE Standards regarding commercial support of continuing pharmacy education. It is the policy of MCPHS University that the speakers and planning committee disclose real or apparent conflicts of interest relating to the topics of the educational activity, that relevant conflicts of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drugs or devices during their presentation.

No funding from industry provided for this event. No exhibitors will be present.
Paige Choi, PharmD, RPh has no relevant financial relationships to disclose.
All CE staff members have no relevant financial relationships to disclose.